Cargando…

Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma

BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yichun, Ye, Dongmei, Kang, Mei, Zhu, Liyang, Yang, Mingwei, Jiang, Jun, Xia, Wanli, Kang, Ningning, Chen, Xiangcun, Wang, Jie, Wang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107680/
https://www.ncbi.nlm.nih.gov/pubmed/33981612
http://dx.doi.org/10.3389/fonc.2021.663679
_version_ 1783689994192289792
author Wang, Yichun
Ye, Dongmei
Kang, Mei
Zhu, Liyang
Yang, Mingwei
Jiang, Jun
Xia, Wanli
Kang, Ningning
Chen, Xiangcun
Wang, Jie
Wang, Fan
author_facet Wang, Yichun
Ye, Dongmei
Kang, Mei
Zhu, Liyang
Yang, Mingwei
Jiang, Jun
Xia, Wanli
Kang, Ningning
Chen, Xiangcun
Wang, Jie
Wang, Fan
author_sort Wang, Yichun
collection PubMed
description BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the recurrent lymph nodes in the cervical and upper mediastinal regions and explore a reasonable CTVnd for PORT in TESCC. METHODS: We retrospectively reviewed patients in our hospital with first cervical and/or upper mediastinal lymph node recurrence (LNR) after upfront esophagectomy. All of these recurrent lymph nodes were plotted on template computed tomography (CT) images with reference to surrounding structures. The recurrence frequency at different stations was investigated and the anatomic distribution of recurrent lymph nodes was analyzed. RESULTS: A total of 119 patients with 215 recurrent lymph nodes were identified. There were 47 (39.5%) patients with cervical LNR and 102 (85.7%) patients with upper mediastinal LNR. The high-risk regions were station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. LNR in the external group of station 104L/R was not common, and LNR was not found in the narrow spaces where the trachea was in close contact with the innominate artery, aortic arch and mediastinal pleura. LNR below the level of the cephalic margin of the superior vena cava was also not common for upper TESCC. CONCLUSIONS: The CTVnd of PORT in the cervical and upper mediastinal regions should cover station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. Based on our results, we proposed a useful atlas for guiding the delineation of CTVnd in TESCC.
format Online
Article
Text
id pubmed-8107680
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81076802021-05-11 Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma Wang, Yichun Ye, Dongmei Kang, Mei Zhu, Liyang Yang, Mingwei Jiang, Jun Xia, Wanli Kang, Ningning Chen, Xiangcun Wang, Jie Wang, Fan Front Oncol Oncology BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the recurrent lymph nodes in the cervical and upper mediastinal regions and explore a reasonable CTVnd for PORT in TESCC. METHODS: We retrospectively reviewed patients in our hospital with first cervical and/or upper mediastinal lymph node recurrence (LNR) after upfront esophagectomy. All of these recurrent lymph nodes were plotted on template computed tomography (CT) images with reference to surrounding structures. The recurrence frequency at different stations was investigated and the anatomic distribution of recurrent lymph nodes was analyzed. RESULTS: A total of 119 patients with 215 recurrent lymph nodes were identified. There were 47 (39.5%) patients with cervical LNR and 102 (85.7%) patients with upper mediastinal LNR. The high-risk regions were station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. LNR in the external group of station 104L/R was not common, and LNR was not found in the narrow spaces where the trachea was in close contact with the innominate artery, aortic arch and mediastinal pleura. LNR below the level of the cephalic margin of the superior vena cava was also not common for upper TESCC. CONCLUSIONS: The CTVnd of PORT in the cervical and upper mediastinal regions should cover station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. Based on our results, we proposed a useful atlas for guiding the delineation of CTVnd in TESCC. Frontiers Media S.A. 2021-04-26 /pmc/articles/PMC8107680/ /pubmed/33981612 http://dx.doi.org/10.3389/fonc.2021.663679 Text en Copyright © 2021 Wang, Ye, Kang, Zhu, Yang, Jiang, Xia, Kang, Chen, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Yichun
Ye, Dongmei
Kang, Mei
Zhu, Liyang
Yang, Mingwei
Jiang, Jun
Xia, Wanli
Kang, Ningning
Chen, Xiangcun
Wang, Jie
Wang, Fan
Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title_full Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title_fullStr Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title_full_unstemmed Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title_short Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
title_sort mapping of cervical and upper mediastinal lymph node recurrence for guiding clinical target delineation of postoperative radiotherapy in thoracic esophageal squamous cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107680/
https://www.ncbi.nlm.nih.gov/pubmed/33981612
http://dx.doi.org/10.3389/fonc.2021.663679
work_keys_str_mv AT wangyichun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT yedongmei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT kangmei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT zhuliyang mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT yangmingwei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT jiangjun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT xiawanli mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT kangningning mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT chenxiangcun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT wangjie mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma
AT wangfan mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma